Vermont Tech Scene
SEE OTHER BRANDS

Exploring the science and technology news of Vermont

Vermont Tech Scene: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vermont Tech Scene.

Press releases published on April 18, 2025

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

SAN CARLOS, Calif., April 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL …

Easy Mining, Steady Profits – PAIRMiner Platform Helps You Achieve Crypto Wealth!

Easy Mining, Steady Profits – PAIRMiner Platform Helps You Achieve Crypto Wealth!

Washington, D.C., USA, April 18, 2025 (GLOBE NEWSWIRE) -- Cryptocurrency Market Experiences a Strong Rebound, PAIRMiner Platform Helps Miners Seize Profit Opportunities Recently, the cryptocurrency market has experienced a strong upward trend, especially …

23andMe Provides Update Regarding Court-Supervised Sale Process

23andMe Provides Update Regarding Court-Supervised Sale Process

SAN FRANCISCO, April 18, 2025 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (“23andMe” or the “Company”) (OTC: MEHCQ), a leading human genetics and biotechnology company, today provided additional information on the protections in place for customer data in …

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

OptimizeRx Corporation Announces Plan for Additional Board of Directors Refreshment

WALTHAM, Mass., April 18, 2025 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today …

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

Regeneron Provides Update on EYLEA HD® (aflibercept) Injection 8 mg Supplemental Biologics License Application

TARRYTOWN, N.Y., April 18, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter (CRL) regarding the supplemental Biologics License …

AMMO, Inc. Completes Sale of Ammunition Manufacturing Assets to Olin Winchester

AMMO, Inc. Completes Sale of Ammunition Manufacturing Assets to Olin Winchester

Sale Transitions AMMO to an E-commerce-Focused Company Accelerating Growth Through GunBroker.com, the Largest Online Marketplace for Firearms, Hunting and Related Products Sale Allows Company to Center its Attention on Innovation, Profitability, and Long- …

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Dupixent® (dupilumab) Approved in the U.S. as the First New Targeted Therapy in Over a Decade for Chronic Spontaneous Urticaria (CSU)

Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years and older living with CSU who remain symptomatic despite …

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Press Release: Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria

Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch and hives compared to placebo In the US, there are more …

Communiqué de presse :  Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée

Communiqué de presse : Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée

Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à plus de 300 000 adultes et adolescents âgés de 12 ans et …

Telnyx Applauds Fifth Circuit Ruling in Favor of AT&T

Telnyx Applauds Fifth Circuit Ruling in Favor of AT&T

Austin, TX, April 18, 2025 (GLOBE NEWSWIRE) -- Telnyx LLC, a leading provider of real-time communications and connectivity solutions, today applauded Thursday’s opinion from the Fifth Circuit vacating the Federal Communications Commission’s (FCC) $57 …

ASUS Introduces Upgraded TUF Gaming A14 for Ultimate Performance

ASUS Introduces Upgraded TUF Gaming A14 for Ultimate Performance

TORONTO, April 18, 2025 (GLOBE NEWSWIRE) -- ASUS today announced an all-new ASUS TUF Gaming A14 equipped with an AMD Ryzen™ AI 7 350 CPU and an NVIDIA® GeForce RTX™ 5060 Laptop GPU. Housed in an incredibly portable and lightweight 14-inch form factor …

Surfshark turns 7 and offers users a special birthday deal

Surfshark turns 7 and offers users a special birthday deal

Leading cybersecurity company Surfshark is celebrating its 7th anniversary. For that occasion, it offers users a limited-time birthday deal. As part of its birthday celebration, Surfshark is offering special pricing across its suite of privacy plans (until …

NordVPN’s travel eSIM app, Saily, preserves nearly 30% of mobile data, independent audit confirms

NordVPN’s travel eSIM app, Saily, preserves nearly 30% of mobile data, independent audit confirms

LONDON, April 18, 2025 (GLOBE NEWSWIRE) -- Saily, a travel eSIM app by the company behind NordVPN, has just completed third party testing of its ad blocker technology benefits. The test performed by West Coast Labs, a leading independent testing lab, …

Dipharma Awarded Bronze Medal by Ecovadis for Sustainability

Dipharma Awarded Bronze Medal by Ecovadis for Sustainability

MILAN, April 18, 2025 (GLOBE NEWSWIRE) -- Dipharma Francis, a global world class Contract Development and Manufacturing Organization (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients (APIs), New Chemical Entities (NCE), and advanced …

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025

Madrigal Pharmaceuticals to Release First-Quarter 2025 Financial Results and Host Webcast on May 1, 2025

CONSHOHOCKEN, Pa., April 18, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), announced today that it …

NordPass wins at Global Tech Awards 2025 for excellence in Cyber Security Technology category

NordPass wins at Global Tech Awards 2025 for excellence in Cyber Security Technology category

LONDON, April 18, 2025 (GLOBE NEWSWIRE) -- NordPass, a leading password manager developed by the cybersecurity experts behind NordVPN, has been named a winner in the Cyber Security Technology (CyberTech) category at the Global Tech Awards 2025. The …

Best Accounting Software for Freelancers (2025): QuickBooks Named Top Accounting Software by Software Experts

Best Accounting Software for Freelancers (2025): QuickBooks Named Top Accounting Software by Software Experts

NEW YORK CITY, April 18, 2025 (GLOBE NEWSWIRE) -- Software Experts has named QuickBooks as the Best Accounting Software for Freelancers in its annual review of tools tailored for independent professionals. The recognition highlights QuickBooks’ …

FARO to Announce Financial Results for the First Quarter 2025 on April 24, 2025

FARO to Announce Financial Results for the First Quarter 2025 on April 24, 2025

LAKE MARY, Fla., April 18, 2025 (GLOBE NEWSWIRE) -- FARO® Technologies, Inc. (Nasdaq: FARO), a global leader in 4D digital reality solutions, today announced that before market open on Thursday, April 24, 2025, it will release its financial results for the …

JuicyChat.AI Redefines NSFW AI Anime Ecosystem, Closes Loop for Creators

JuicyChat.AI Redefines NSFW AI Anime Ecosystem, Closes Loop for Creators

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- JuicyChat.AI is redefining the landscape of NSFW AI-powered anime content with a groundbreaking ecosystem that prioritizes NSFW AI creators and their core needs. With a vision to build a closed-loop creation …

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Saint Herblain (France), April 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service